• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸地尔硫䓬对室上性心动过速的电生理效应。

Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia.

作者信息

Rozanski J J, Zaman L, Castellanos A

出版信息

Am J Cardiol. 1982 Feb 18;49(3):621-8. doi: 10.1016/s0002-9149(82)80021-0.

DOI:10.1016/s0002-9149(82)80021-0
PMID:7058770
Abstract

The effects of intravenous diltiazem hydrochloride (0.25 mg/kg body weight) were studied in eight patients with nine episodes of supraventricular tachycardia. Five episodes of tachycardia were due to atrioventricular (A-V) nodal reentry (group A), two were due to retrograde utilization of a concealed A-V accessory pathway (group B) and two were episodes of atrial fibrillation (group C). Intravenous administration of diltiazem slowed the ventricular rate in eight of nine episodes of tachycardias. Supraventricular tachycardia was terminated within 2 minutes after intravenous diltiazem in four of five patients in group A, and one of two in group B. Cycle length alternation was observed before termination of the arrhythmia in two patients from group A. In group C the ventricular response slowed but also became regular during atrial fibrillation. Although diltiazem depressed both anterograde and retrograde conduction as assessed by programmed stimulation, tachycardia termination or slowing or alternation of cycle length all occurred because of the effects of diltiazem predominantly on anterograde A-V nodal properties during supraventricular tachycardia. Although no statistical conclusions can be made from this limited study, it appears that diltiazem has significant depressant electrophysiologic effects on both anterograde and retrograde A-V nodal function as assessed by programmed stimulation during sinus rhythm. Further electrophysiologic studies are needed before determining the clinical efficacy of this agent for treatment or prophylaxis of recurrent supraventricular tachycardias.

摘要

对8例患者的9次室上性心动过速发作研究了静脉注射盐酸地尔硫䓬(0.25mg/kg体重)的效果。5次心动过速发作是由于房室(A-V)结折返(A组),2次是由于隐匿性A-V旁路的逆向利用(B组),2次是房颤发作(C组)。静脉注射地尔硫䓬使9次心动过速发作中的8次心室率减慢。A组5例患者中有4例、B组2例中有1例在静脉注射地尔硫䓬后2分钟内室上性心动过速终止。A组2例患者在心律失常终止前观察到周期长度交替。C组在房颤期间心室反应减慢但也变得规则。尽管通过程控刺激评估地尔硫䓬抑制了前向和逆向传导,但心动过速的终止、减慢或周期长度的交替均是由于地尔硫䓬在室上性心动过速期间主要对前向A-V结特性的影响所致。尽管从这项有限的研究中无法得出统计学结论,但在窦性心律期间通过程控刺激评估,地尔硫䓬似乎对前向和逆向A-V结功能均有显著的抑制性电生理作用。在确定该药物治疗或预防复发性室上性心动过速的临床疗效之前,还需要进一步的电生理研究。

相似文献

1
Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia.盐酸地尔硫䓬对室上性心动过速的电生理效应。
Am J Cardiol. 1982 Feb 18;49(3):621-8. doi: 10.1016/s0002-9149(82)80021-0.
2
Effects of intravenous diltiazem administration in patients with inducible tachycardia.
Eur Heart J. 1985 Oct;6(10):882-90. doi: 10.1093/oxfordjournals.eurheartj.a061776.
3
Intravenous diltiazem for the treatment of supraventricular tachycardia.静脉注射地尔硫䓬治疗室上性心动过速。
Clin Cardiol. 1986 Apr;9(4):145-9. doi: 10.1002/clc.4960090403.
4
Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias.静脉注射地尔硫䓬对阵发性室上性快速心律失常急性处理的有益作用。
Circulation. 1983 Jan;67(1):88-94. doi: 10.1161/01.cir.67.1.88.
5
Intravenous diltiazem in patients with paroxysmal re-entrant supraventricular tachycardia.
Int J Cardiol. 1989 May;23(2):215-21. doi: 10.1016/0167-5273(89)90250-7.
6
Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
Am J Cardiol. 1984 Sep 1;54(6):544-9. doi: 10.1016/0002-9149(84)90245-5.
7
[Effects of diltiazem in supraventricular paroxysmal tachyarrhythmias].[地尔硫䓬对室上性阵发性快速心律失常的影响]
G Ital Cardiol. 1986 Sep;16(9):776-81.
8
Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.静脉注射地尔硫䓬对复发性室上性心动过速患者的电生理效应。
Can J Cardiol. 1985 Sep-Oct;1(5):302-5.
9
The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.地尔硫䓬和维拉帕米对房室传导及房室折返性心动过速的比较效应
Circ Res. 1983 Feb;52(2 Pt 2):I163-8.
10
Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.静脉注射地尔硫䓬治疗室上性快速心律失常。
Acta Cardiol. 1995;50(2):125-34.

引用本文的文献

1
Effects of cardioactive medications on retrograde conduction: continuing relevance for current devices.
J Interv Card Electrophysiol. 2006 Jan;15(1):49-55. doi: 10.1007/s10840-006-7621-z.
2
Effects of halothane and calcium entry blockers on atrioventricular conduction-a comparative study of verapamil, diltiazem, and nifedipine.氟烷和钙通道阻滞剂对房室传导的影响——维拉帕米、地尔硫䓬和硝苯地平的比较研究
J Anesth. 1988 Sep 1;2(2):219-26. doi: 10.1007/s0054080020219.
3
Interactions of a new beta-blocker, celiprolol, with the calcium antagonists, diltiazem and nifedipine, on atrioventricular conduction.一种新型β受体阻滞剂塞利洛尔与钙拮抗剂地尔硫䓬和硝苯地平对房室传导的相互作用。
Cardiovasc Drugs Ther. 1995 Jun;9(3):445-57. doi: 10.1007/BF00879034.
4
Diltiazem. A review of its pharmacology and therapeutic use in older patients.地尔硫䓬。老年患者药理学及治疗应用综述。
Drugs Aging. 1993 Jul-Aug;3(4):363-90. doi: 10.2165/00002512-199303040-00007.
5
Calcium antagonists. Clinical use in the treatment of arrhythmias.钙拮抗剂。在心律失常治疗中的临床应用。
Drugs. 1983 Feb;25(2):125-53. doi: 10.2165/00003495-198325020-00003.
6
Diltiazem. A review of its pharmacological properties and therapeutic efficacy.地尔硫䓬。其药理特性与治疗效果综述。
Drugs. 1985 May;29(5):387-454. doi: 10.2165/00003495-198529050-00001.
7
Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.钙通道拮抗剂。第三部分:在高血压和室上性心律失常中的应用及疗效比较。次要适应症。
Cardiovasc Drugs Ther. 1988 Mar;1(6):625-56. doi: 10.1007/BF02125750.
8
Relationship between the cardiovascular effects and both plasma and myocardial levels of clentiazem, a new benzothiazepine calcium antagonist, in anesthetized dogs.
Cardiovasc Drugs Ther. 1991 Dec;5(6):997-1003. doi: 10.1007/BF00143527.